Keyword Index

A

  • ACE2 ACE2-Ang (1–7)/ SIRT1 is a Prospective Nephroprotective Panel of Dize in CCl4- Induced Kidney Injury. [Volume 9, Issue 1, 2025, Pages 1-11]
  • Antioxidant activity Phytochemical Investigation and in vitro Antioxidant Activities of Cleome amblyocarpa Cultivated in North Sinai. [Volume 9, Issue 2, 2025, Pages 1-7]
  • ApaI The role of vitamin D receptor gene polymorphisms in Type 2 Diabetes Mellitus Susceptibility and Pathogenesis [Volume 9, Issue 1, 2025, Pages 48-57]

B

  • BsmI The role of vitamin D receptor gene polymorphisms in Type 2 Diabetes Mellitus Susceptibility and Pathogenesis [Volume 9, Issue 1, 2025, Pages 48-57]

C

  • CB-839 Targeting Glutamine Metabolismm: A Novel Approach to Combat Hepatic Fibrosis [Volume 9, Issue 1, 2025, Pages 19-30]
  • CCl4 ACE2-Ang (1–7)/ SIRT1 is a Prospective Nephroprotective Panel of Dize in CCl4- Induced Kidney Injury. [Volume 9, Issue 1, 2025, Pages 1-11]
  • Cleome amblyocarpa Phytochemical Investigation and in vitro Antioxidant Activities of Cleome amblyocarpa Cultivated in North Sinai. [Volume 9, Issue 2, 2025, Pages 1-7]
  • Colon Impact of Mucoadhesive Membrane Formulations on Bioavailability [Volume 9, Issue 3, 2025, Pages 18-31]

D

  • Diabetic kidney disease Overview of key molecular processes behind diabetic nephropathy [Volume 9, Issue 3, 2025, Pages 32-39]
  • Diminazene ACE2-Ang (1–7)/ SIRT1 is a Prospective Nephroprotective Panel of Dize in CCl4- Induced Kidney Injury. [Volume 9, Issue 1, 2025, Pages 1-11]
  • DPPH Phytochemical Investigation and in vitro Antioxidant Activities of Cleome amblyocarpa Cultivated in North Sinai. [Volume 9, Issue 2, 2025, Pages 1-7]

F

  • FokI The role of vitamin D receptor gene polymorphisms in Type 2 Diabetes Mellitus Susceptibility and Pathogenesis [Volume 9, Issue 1, 2025, Pages 48-57]
  • FRAP Phytochemical Investigation and in vitro Antioxidant Activities of Cleome amblyocarpa Cultivated in North Sinai. [Volume 9, Issue 2, 2025, Pages 1-7]

G

  • GLS Targeting Glutamine Metabolismm: A Novel Approach to Combat Hepatic Fibrosis [Volume 9, Issue 1, 2025, Pages 19-30]

H

  • HBV Occult Hepatitis B and C among injection drug users (IDUs): An Overlooked Obstacle in Global Health Efforts. [Volume 9, Issue 1, 2025, Pages 12-18]
  • HCV Occult Hepatitis B and C among injection drug users (IDUs): An Overlooked Obstacle in Global Health Efforts. [Volume 9, Issue 1, 2025, Pages 12-18]
  • Hepatic fibrosis Targeting Glutamine Metabolismm: A Novel Approach to Combat Hepatic Fibrosis [Volume 9, Issue 1, 2025, Pages 19-30]
  • Heterocyclic Steroids: ADME Analysis Computational Evaluation of Heterocyclic Steroids: Physicochemical and Pharmacoki-netic Insights [Volume 9, Issue 3, 2025, Pages 8-17]

I

  • IBS Impact of Mucoadhesive Membrane Formulations on Bioavailability [Volume 9, Issue 3, 2025, Pages 18-31]
  • Inflammation Overview of key molecular processes behind diabetic nephropathy [Volume 9, Issue 3, 2025, Pages 32-39]

L

  • Lipinski's Rule Computational Evaluation of Heterocyclic Steroids: Physicochemical and Pharmacoki-netic Insights [Volume 9, Issue 3, 2025, Pages 8-17]
  • Losartan A Brief Review on Analytical Techniques for Quantitative Determination ‎of Rosuvastatin and Losartan in Different Matrices.‎ [Volume 9, Issue 1, 2025, Pages 31-47]

M

  • Metagenomics sequencing Nasal Microbiome Profile of Healthy Subjects [Volume 9, Issue 2, 2025, Pages 8-14]
  • Mimusops Triterpenoid and Triterpenoid Saponins from Genus Mimusops: A Review [Volume 9, Issue 2, 2025, Pages 23-44]
  • Mucoadhesive Polymer Impact of Mucoadhesive Membrane Formulations on Bioavailability [Volume 9, Issue 3, 2025, Pages 18-31]

N

  • NASH Apoptosis and necroptosis pathways in nonalcoholic steatohepatitis; New strategy for treatment [Volume 9, Issue 1, 2025, Pages 58-69]
  • Necroptosis Apoptosis and necroptosis pathways in nonalcoholic steatohepatitis; New strategy for treatment [Volume 9, Issue 1, 2025, Pages 58-69]
  • Neurodegeneration Sinapic Acid: A Brief Review of its Therapeutic Potential and Molecular Targets in Parkinson’s Disease [Volume 9, Issue 3, 2025, Pages 1-7]

O

  • Occult hepatitis B Occult Hepatitis B and C among injection drug users (IDUs): An Overlooked Obstacle in Global Health Efforts. [Volume 9, Issue 1, 2025, Pages 12-18]
  • Occult hepatitis C Occult Hepatitis B and C among injection drug users (IDUs): An Overlooked Obstacle in Global Health Efforts. [Volume 9, Issue 1, 2025, Pages 12-18]
  • Oxidative Stress Sinapic Acid: A Brief Review of its Therapeutic Potential and Molecular Targets in Parkinson’s Disease [Volume 9, Issue 3, 2025, Pages 1-7]
  • Oxidative Stress Overview of key molecular processes behind diabetic nephropathy [Volume 9, Issue 3, 2025, Pages 32-39]

P

  • Parkinson's disease Sinapic Acid: A Brief Review of its Therapeutic Potential and Molecular Targets in Parkinson’s Disease [Volume 9, Issue 3, 2025, Pages 1-7]
  • Pharmacological Triterpenoid and Triterpenoid Saponins from Genus Mimusops: A Review [Volume 9, Issue 2, 2025, Pages 23-44]
  • Pharmacological effects Estragole and anethole as potential hazardous compounds in products: extraction , analysis and pharmacological effects. [Volume 9, Issue 2, 2025, Pages 15-22]

Q

R

  • Ras ACE2-Ang (1–7)/ SIRT1 is a Prospective Nephroprotective Panel of Dize in CCl4- Induced Kidney Injury. [Volume 9, Issue 1, 2025, Pages 1-11]

S

  • Shotgun Nasal Microbiome Profile of Healthy Subjects [Volume 9, Issue 2, 2025, Pages 8-14]
  • Sinapic acid Sinapic Acid: A Brief Review of its Therapeutic Potential and Molecular Targets in Parkinson’s Disease [Volume 9, Issue 3, 2025, Pages 1-7]
  • SIRT1 ACE2-Ang (1–7)/ SIRT1 is a Prospective Nephroprotective Panel of Dize in CCl4- Induced Kidney Injury. [Volume 9, Issue 1, 2025, Pages 1-11]

T

  • TaqI The role of vitamin D receptor gene polymorphisms in Type 2 Diabetes Mellitus Susceptibility and Pathogenesis [Volume 9, Issue 1, 2025, Pages 48-57]
  • TGF-β1 Targeting Glutamine Metabolismm: A Novel Approach to Combat Hepatic Fibrosis [Volume 9, Issue 1, 2025, Pages 19-30]
  • Treatment Apoptosis and necroptosis pathways in nonalcoholic steatohepatitis; New strategy for treatment [Volume 9, Issue 1, 2025, Pages 58-69]

V

  • VDR gene polymorphisms The role of vitamin D receptor gene polymorphisms in Type 2 Diabetes Mellitus Susceptibility and Pathogenesis [Volume 9, Issue 1, 2025, Pages 48-57]